The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to biologics market will
help companies and investors design strategic landscapes.
Microbial was the largest segment with a revenue share of
58.19% in
2024.
Horizon Databook has segmented the Global biologics market based on microbial, mammalian, others biologics source covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Biologics Biologics Source Outlook (Revenue, USD Million, 2018-2030)
- Microbial
- Mammalian
- Others Biologics Source
- Global Biologics Biologics Product Outlook (Revenue, USD Million, 2018-2030)
- Vaccines
- Recombinant Proteins
- Antisense & RNAi Therapeutics
- Others Product
- Monoclonal Antibodies
- MABs by Application
- Therapeutic
- Diagnostics
- Protein Purification
- Others MABs by Application
- MABs by Type
- Humanized
- Chimeric
- Human
- Murin
- Others MABs by Type
- Global Biologics Disease Category Outlook (Revenue, USD Million, 2018-2030)
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others Disease Category
- Oncology
- Monoclonal antibodies (MABs)
- Vaccines
- Antisense & RNAi Therapeutics
- Recombinant Proteins
- Others Oncology
- Infectious Diseases
- Vaccines
- MABs
- Antisense & RNAi Therapeutics
- Recombinant Proteins
- Others Infectious Diseases
- Global Biologics Manufacturing Outlook (Revenue, USD Million, 2018-2030)
Reasons to
subscribe to Global biologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global biologics market databook
-
Our clientele includes a mix of biologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global biologics market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global biologics market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.